[1] |
王旖旎, 王昭, 张嘉, 等. 成人噬血细胞综合征基因型特点及家系调查[J]. 临床和实验医学杂志, 2020,19(13):1345⁃1349. doi: 10.3969/j.issn.1671⁃4695.2020.13.001.
|
[2] |
Knaak C, Nyvlt P, Schuster FS, et al. Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH⁃2004 criteria and HScore[J]. Crit Care, 2020,24(1):244. doi: 10.1186/s13054⁃020⁃02941⁃3.
|
[3] |
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015,17(5):405⁃424. doi: 10.1038/gim.2015.30.
|
[4] |
Lee DE, Martinez⁃Escala ME, Serrano LM, et al. Hemophagocytic lymphohistiocytosis in cutaneous T⁃cell lymphoma[J]. JAMA Dermatol, 2018,154(7):828⁃831. doi: 10.1001/jamadermatol. 2018.1264.
|
[5] |
Imataki O, Uchida S, Yokokura S, et al. Small primary cutaneous γδT⁃cell lymphoma lesions successfully treated with pralatrexate[J]. Clin Nucl Med, 2019,44(2):e85⁃e86. doi: 10. 1097/RLU.0000000000002409.
|
[6] |
Alexander RE, Webb AR, Abuel⁃Haija M, et al. Rapid progression of primary cutaneous gamma⁃delta T⁃cell lymphoma with an initial indolent clinical presentation[J]. Am J Dermatopathol, 2014,36(10):839⁃842. doi: 10.1097/DAD.0b013 e318289c9b8.
|
[7] |
Daniels J, Doukas PG, Escala M, et al. Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas[J]. Nat Commun, 2020,11(1):1806. doi: 10.1038/s41467⁃020⁃15572⁃7.
|
[8] |
Merrill ED, Agbay R, Miranda RN, et al. Primary cutaneous T⁃cell lymphomas showing gamma⁃delta (γδ) phenotype and predominantly epidermotropic pattern are clinicopathologically distinct from classic primary cutaneous γδ T⁃cell lymphomas[J]. Am J Surg Pathol, 2017,41(2):204⁃215. doi: 10.1097/PAS. 0000000000000768.
|
[9] |
Yabe M, Medeiros LJ, Wang SA, et al. Distinguishing between hepatosplenic T⁃cell lymphoma and γδ T⁃cell large granular lymphocytic leukemia: a clinicopathologic, immunophenotypic, and molecular analysis[J]. Am J Surg Pathol, 2017,41(1):82⁃93. doi: 10.1097/PAS.0000000000000743.
|
[10] |
Chen X, Zhao S, Liu L, et al. Flow cytometric pattern of TCRVδ subtype expression rapidly identifies γδT cell lymphoma[J]. Front Oncol, 2020,10:844. doi: 10.3389/fonc.2020.00844.
|
[11] |
Aricò M, Danesino C, Pende D, et al. Pathogenesis of haemophagocytic lymphohistiocytosis[J]. Br J Haematol, 2001,114(4):761⁃769. doi: 10.1046/j.1365⁃2141.2001.02936.x.
|
[12] |
Swerdlow SH, Jaffe ES, Brousset P, et al. Cytotoxic T⁃cell and NK⁃cell lymphomas: current questions and controversies[J]. Am J Surg Pathol, 2014,38(10):e60⁃71. doi: 10.1097/PAS.00000000 00000295.
|
[13] |
Liu YZ, Bi LQ, Chang GL, et al. Clinical characteristics of extranodal NK/T⁃cell lymphoma⁃associated hemophagocytic lymphohistiocytosis[J]. Cancer Manag Res, 2019,11:997⁃1002. doi: 10.2147/CMAR.S183784.
|
[14] |
Zhu GH, Zhang LP, Li ZG, et al. Associations between PRF1 Ala91Val polymorphism and risk of hemophagocytic lymphohistiocytosis: a meta⁃analysis based on 1366 subjects[J]. World J Pediatr, 2020,16(6):598⁃606. doi: 10.1007/s12519⁃020⁃00351⁃7.
|
[15] |
Ueda I, Ishii E, Morimoto A, et al. Correlation between phenotypic heterogeneity and gene mutational characteristics in familial hemophagocytic lymphohistiocytosis (FHL)[J]. Pediatr Blood Cancer, 2006,46(4):482⁃488. doi: 10.1002/pbc.20511.
|
[16] |
Chen X, Zhang Y, Wang F, et al. Germline cytotoxic lymphocytes defective mutations in Chinese patients with lymphoma[J]. Oncol Lett, 2017,14(5):5249⁃5256. doi: 10.3892/ol.2017.6898.
|
[17] |
Wang Y, Wang Z, Zhang J, et al. Genetic features of late onset primary hemophagocytic lymphohistiocytosis in adolescence or adulthood[J/OL]. PLoS One, 2014,9(9):e107386. doi: 10.1371/journal.pone.0107386.
|
[18] |
Basheer A, Padhi S, Nagarajan R, et al. Hemophagocytic lymphohistiocytosis in association with primary cutaneous anaplastic large cell lymphoma[J]. Case Rep Hematol, 2014,2014:384123. doi: 10.1155/2014/384123.
|
[19] |
Ciambotti B, Mussolin L, d′Amore ES, et al. Monoallelic mutations of the perforin gene may represent a predisposing factor to childhood anaplastic large cell lymphoma[J]. J Pediatr Hematol Oncol, 2014, 36(6): e359⁃e365. doi:10.1097/MPH.0000 000000000073.
|
[20] |
Aksu T, Bayhan T, Gülhan B, et al. Children with lymphoma presenting with hemophagocytic lymphohistiocytosis[J]. Turk J Pediatr, 2020,62(2):284⁃288. doi: 10.24953/turkjped.2020.02. 016.
|
[21] |
Willemze R. Cutaneous lymphomas with a panniculitic presentation[J]. Semin Diagn Pathol, 2017,34(1):36⁃43. doi: 10.1053/j.semdp.2016.11.009.
|
[22] |
Pincus LB, LeBoit PE, McCalmont TH, et al. Subcutaneous panniculitis⁃like T⁃cell lymphoma with overlapping clinicopathologic features of lupus erythematosus: coexistence of 2 entities?[J]. Am J Dermatopathol, 2009,31(6):520⁃526. doi: 10.1097/DAD.0b013e3181a84f32.
|
[23] |
Gayden T, Sepulveda FE, Khuong⁃Quang DA, et al. Germline HAVCR2 mutations altering TIM⁃3 characterize subcutaneous panniculitis⁃like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome[J]. Nat Genet, 2018,50(12):1650⁃1657. doi: 10.1038/s41588⁃018⁃0251⁃4.
|
[24] |
中国抗癌协会淋巴瘤专业委员会. 淋巴瘤相关噬血细胞综合征诊治中国专家共识[J]. 中华医学杂志, 2018,98(18):1389⁃1393. doi: 10.3760/cma.j.issn.0376⁃2491.2018.18.004.
|
[25] |
Hansen S, Alduaij W, Biggs CM, et al. Ruxolitinib as adjunctive therapy for secondary hemophagocytic lymphohistiocytosis: a case series[J]. Eur J Haematol, 2021,106(5):654⁃661. doi: 10. 1111/ejh.13593.
|
[26] |
Wang J, Zhang R, Wu X, et al. Ruxolitinib⁃combined doxorubicin⁃etoposide⁃methylprednisolone regimen as a salvage therapy for refractory/relapsed haemophagocytic lymphohistiocytosis: a single⁃arm, multicentre, phase 2 trial[J]. Br J Haematol, 2021,193(4):761⁃768. doi: 10.1111/bjh.17331.
|
[27] |
Wang H, Gu J, Liang X, et al. Low dose ruxolitinib plus HLH⁃94 protocol: a potential choice for secondary HLH[J]. Semin Hematol, 2020,57(1):26⁃30. doi: 10.1053/j.seminhematol.2018. 07.006.
|